Top-Rated Analysts

Oppenheimer Maintains Outperform On Zogenix Following Acquisition Of Brabant Pharma

In a research report issued Tuesday, Oppenheimer analyst Akiva Felt maintained an Outperform rating on Zogenix (NASDAQ:ZGNX) with a price target of $2.50, …

UPDATE: Cantor Remain Buyers Of Twitter Following Earnings

In a research report released Tuesday, Cantor analyst Youssef Squali assigned a Buy rating on Twitter Inc (NYSE:TWTR) with a $58 price target, as the …

Twitter: Recent Pullback Creates Opportunity But Reducing PT, Says Topeka

In a research report issued today, Topeka Capital analyst Victor Anthony reiterated a Buy rating on Twitter Inc (NYSE:TWTR) and reduced his price target to …

Cantor Maintains Buy On Facebook Ahead Of 3Q Results

In a research report released Monday, Cantor analyst Youssef Squali assigned a Buy rating on Facebook (NASDAQ:FB) with an $82 price target. The report …

Cantor Sets Expectations On LinkedIn Ahead Of 3Q14 Earnings

In a research report issued today, Cantor analyst Youssef Squali maintained a Buy rating on LinkedIn Corp (NYSE:LNKD) with a $250 price target, ahead …

Cantor Reiterates Hold On Shares Of VistaPrint NV, $52 PT

In a research report issued this morning, Cantor analyst Youssef Squali reiterated a Hold rating on VistaPrint NV (NASDAQ:VPRT) with a price target …

Shutterfly: In-Line Quarter Likely Ahead Of The Seasonally Strong 4Q

In a research report published this morning, Cantor analyst Youssef Squali assigned a Buy rating on Shutterfly (NASDAQ:SFLY) with a $60 price target, …

Twitter: Solid 3Q:14 Results Are Expected, Says Cantor

In a research report issued this morning, Cantor analyst Youssef Squali maintained a Buy rating on Twitter Inc (NYSE:TWTR) with a $58 price target, …

Cantor Maintains Buy On comScore Shares, $42 PT

In a research note released this morning, Cantor analyst Youssef Squali maintained a Buy rating on comScore Inc (NASDAQ:SCOR) with a price target …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts